Skip to content

A Study of Disposable Transnasal Esophagoscope

A Novel Disposable Transnasal Esophagoscope: a Prospective Pilot Trial of Feasibility, Safety and Tolerance

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01360515
Enrollment
50
Registered
2011-05-25
Start date
2010-10-31
Completion date
2011-02-28
Last updated
2012-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal Disease, Esophageal Varices, Gastroesophageal Reflux

Keywords

esophagoscope, esophageal disease, gastroesophageal reflux, esophageal varices

Brief summary

This is a pilot study of a novel disposable transnasal esophagoscope for feasibility, safety and tolerance.

Detailed description

A disposable, transnasal esophagoscope, E.G. ScanTM was developed by IntroMedic Co. Ltd. (Seoul, Korea). This device was designed to allow patient to undergo endoscopy with minimum pain without sedation. This endoscopy system consists of thin probe with a CMOS camera, controller and simple display system. This system is light enough to carry and does occupy much space, and thus, it can be used at patient bed sides in intensive care units, in emergency rooms, and even in doctor's offices.

Interventions

None listed

Sponsors

Yonsei University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. aged 20 years or older 2. endoscopy indicated for reflux symptoms (heartburn, epigastric soreness and/or regurgitation), dyspepsia (epigastric discomfort, bloating, early satiety), or non-cardiogenic chest pain, or known or suspected to have esophageal varices, infectious esophagitis, or other esophageal disease based on their medical history 3. a written informed consent form

Exclusion criteria

1. history or symptoms of severe rhinitis and sinusitis 2. symptoms of acute respiratory inflammation at the time of examination 3. abnormal anatomy of the nasal cavity or nasopharynx due to nasal tumors or previous nasopharyngeal surgery 4. taking anticoagulants such as coumadin 5. patients for whom a EGD could not be performed

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026